Adult ALL: Treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol [21]

Leukemia

Volumn 21, Issue 10, 2007, Pages 2230-2233

  Bajel, A ^a   George, B ^a   Mathews, V ^a   Viswabandya, A ^a   Kavitha, M L ^a   Srivastava, A ^a   Chandy, M ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; STEROID; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; BONE MARROW BIOPSY; CAUCASIAN; CENTRAL NERVOUS SYSTEM METASTASIS; CEREBROSPINAL FLUID ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG MEGADOSE; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; GIEMSA STAIN; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INDIAN; LETTER; LEUKEMIA REMISSION; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 34548782704     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404785     Document Type: Letter

References (8)

1. Hoelzer D, Thiel E, Loffler B, Buchner T, Ganser A, Heil G et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123-131.
2. Durrant IJ, Prentice HG, Richards SM. Intensification of treatment for adults with acute lymphoblastic leukaemia: Results of U.K. Medical Research council randomized trial UKALL XA. Br J Haematol 1997; 99: 84-92.
3. Annino L, Vegna ML, Camera A, Specchia G, Visan G, Fioritoni G et al. Treatment of adult acute lymphoblastic leukemia (ALL): Long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-871.
4. Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98: 1337-1354.
5. Chandy M. Childhood acute lymphoblastic leukemia in India: An approach to management in a three-tier society. Med Pediatr Oncol 1995; 25: 197-203.
6. Raje N, Pal S, Vaidya S, Gopal R, Parikh P, Saikia T et al. Adult acute lymphoblastic leukemia: Results of an aggressive regimen in India. Leuk Lymphoma 1994; 14: 285-290.
7. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94 1209-1217.
8. Gökbuget N, Hoelzer D, Arnold R, Bohme A, Bartram CR, Freund M et al. Treatment of adult ALL according to the protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am 2000; 14: 1307-1325.